Plain-English translation of NCT00230308 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Stanford University are studying tissue samples from patients with head and neck cancer to discover new proteins and genes involved in how these cancers develop and progress. By understanding these biological changes, scientists hope to create better ways to diagnose and treat head and neck cancer in the future.
Currently, doctors need better tools to understand what drives head and neck cancers and how to treat them more effectively. This study aims to fill that gap by identifying new biological targets that could lead to improved therapies.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will collect small tissue samples during your scheduled head and neck cancer surgery—this is part of the tissue that would normally be removed anyway. The study involves no additional procedures beyond your standard surgical care. Your samples will be analyzed to identify new proteins and genes that might help develop future treatments.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States
Collaborators
National Cancer Institute (NCI), National Institutes of Health (NIH)
Enrollment target
~500 participants
Started
April 2002
Primary completion
June 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nikita Bedi
Stanford University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.